Monte Rosa Therapeutics Inc (GLUE)
Cost of Revenue
$2.03M
TTM · Period ending: · USD
GLUE Cost of Revenue
Latest reported$2.03Mperiod ending
Latest reported$2.03Mperiod ending
GLUE TTM Cost of Revenue ($0.00 → $2.03M)
TTM cost of revenue
High-resolution chart · PNG
GLUE cost of revenue history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 2,029,000 | |
| 2,029,000 | |
| 0 | |
| 0 | |
| 0 | |
| 2,060,000 | |
| 3,957,000 | |
| 3,957,000 | |
| 3,957,000 | |
| 1,897,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |